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ABSTRACT
Despite the ubiquitous use over the past 150 years, the functions of the current medical needle are facilitated only by mechanical
shear and cutting by the needle tip, i.e. the lancet. In this study, we demonstrate how nonlinear ultrasonics (NLU) extends
the functionality of the medical needle far beyond its present capability. The NLU actions were found to be localized to the
proximity of the needle tip, the SonoLancet, but the effects extend several millimeters from the physical needle boundary. The
observed nonlinear phenomena, transient cavitation, fluid streams, translation of micro- and nanoparticles and atomization,
were quantitatively characterized. In the fine-needle biopsy application, the SonoLancet contributed to obtaining tissue cores
with increase in tissue yield by 3-6x in different tissue types compared to conventional needle biopsy technique using the same
21G needle. In conclusion, the SonoLancet enhances adequacy of tissue biopsy for many precision medicine applications
including molecular diagnostics. The same mechanisms have the potential to advance several other applications relevant to
precision medicine, including drug or gene delivery, cell modulation, and minimally invasive surgical procedures.
Introduction
The antecedent of the medical lancet was described by Hippocrates for the purpose of puncturing and draining pus1. Currently
the lancet, a small lance2, is widely employed in medical cutting and piercing devices, e.g. hypodermic needles, surgical tools
and tissue sampling needle biopsy devices. Structurally a lancet typically has at least two converging edges and a sharp tip3.
When pressed against or moved along a tissue interface, the lancet’s purpose is to utilize manually mechanical forces to separate
one structure from another in order to achieve or enable a medical purpose4. The medical needle, employing lancet-shape
or other needle tip geometries5, is a common tool in healthcare, exemplified by the estimated 16 billion annual injections
worldwide6. However, the functions of the needle tip is limited to mechanical shear and cutting by the needle tip. Therefore,
applications of medical needle still have substantial functional limitations related to pain7, precision and localization8 and for
needle biopsies, adequacy with regard to quality and quantity of tissue yield9.
An example of a field limited by current functions of a medical needle is needle biopsy for cancer diagnosis. In fact,
the insertion force of a needle exerted on the tissue can imperil the quality of biomarkers, which are of high interest in
precision medicine applications as they are used to classify a disease or determine a treatment10, 11. To provide a personalized
cancer therapy, histological and molecular tissue samples are required. However, up to 34% of histological and up to 50%
molecular assessments fail, because of obtaining diagnostically insufficient sample characterized by limited quantity of obtained
pathological cells or nucleic acids9, 12. Insufficiently adequate biopsies induce a burden on the patients due to extended wait
times before obtaining the diagnosis13. The time pressure to start the therapy can lead to the treatment initiation with inadequate
information. Therefore, ways to improve tissue yield, while not compromising safety, are urgently needed as an enabler for
precision oncology.
During the last decades, therapeutic ultrasonics have demonstrated an enormous potential in various medical applications,
e.g. tumor ablation14, blood brain barrier opening15, management of essential tremor16, hyperthermia17, targeted drug
delivery18, lithotripsy19, histotripsy20, sonophoresis21, sonoporation22 and ultrasonic scalpels23. Applications that are primarily
non-thermal15, 16, 18–23 rely on selective or combinatory use of NLU phenomena such as cavitation24, acoustic radiation force25,
acoustic streaming26, atomization27 and shock waves28. In contrast, thermal applications employ ultrasonics to induce heating
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within a limited volume14, 17.
Actuation of medical needles by ultrasound has been observed to induce tissue movement that can help with localizing the
needle under Doppler ultrasound29, 30 or to reduce penetration resistance of the needle31, 32. In conjunction with microneedles,
low frequency mechanical oscillations in the kHz range have been used for oocyte micro-dissection33, to enhance the
microneedle penetration into mouse embryos34, fish eggs35 and oocytes36, and subsequently to improve oocyte viability for
in vitro fertilization37. However, until now, the potential of NLU extending beyond the needle tip has been overlooked as a
way to add value to the function of medical needles. In fact, the NLU can generate acoustic force fields providing a precise
manipulation of entities selectively closer or at a farther distance from the sound source.
Localized control of cavitation, translation of micro/nanoparticles, microbubbles and fluids inside tissues or bodily
cavities, generation of microdroplets are examples of nonlinear phenomena that could contribute to various precision medicine
applications. Examples of such medical applications include localized and personalized therapies, such as drug or gene
delivery into cells38, permeation of tissue allowing entry of therapeutics (e.g. as ultrasonically mediated blood brain barrier
opening)39, 40, minimally invasive surgical interventions by homogenizing tissues41, fractionation of calculi42 and delivery of
therapeutic agents such as drugs or antiseptics in pulmonary conditions43. However, the possibilities of the widely accepted
and used medical needle has been underexplored as a way to mediate and facilitate ultrasonic actuation at a target site. The
conventional medical needle could be considered as a minimally invasive and cost-effective enabler of many of precision
medicine applications if its current functions extended beyond its current roles.
Based on these premises, we set out to investigate how adding ultrasound to a conventional medical needle could change its
conventional functions. We first demonstrate how ultrasound emission could be localized at a tip of a conventional medical
needle, as an energy source for NLU around the needle tip. From micrometer to millimeter scale, we quantitatively characterize
the NLU effects, such as cavitation, acoustic radiation force and atomization spatially reaching beyond the physical lancet;
we define the confined volume around the needle tip exhibiting pronounced nonlinear effects as the SonoLancet. We then
demonstrate the influence of the SonoLancet in fine-needle biopsy application as an enhancer of tissue yield. Finally, we discuss
the potential of SonoLancet as an enabler for other selected applications relevant to precision medicine.
Results
Localization of ultrasound near the needle tip
To demonstrate that the nonlinear effects can be generated near an ultrasonically actuated medical needle (Figure 1A(1-3)), a 21
gauge hypodermic needle was selected, because it represents a common medical needle. Moreover, needles of this diameter or
less (fine needles) induce less tissue trauma than larger needles. The selected geometry permits access to the needle hub with a
variety of adjuvant devices commonly used in medical practice, e.g. tubing, syringe, vacutainer; for this study we selected a
10 mL syringe.
We employed an axially translating Langevin transducer as a sound source, which was coupled to an S-shaped waveguide
connected to a medical needle (Figure 1A(1)). Using the waveguide, the longitudinal mode waves of the ultrasound transducer
are converted to flexural mode waves in the needle. Reflection of the wave from the needle tip allowed generation of a flexural
standing wave between the tips of the needle and the waveguide. Moreover, the converging structure of the medical needle bevel
gives geometric amplification of the wave towards the needle extremity. As a consequence of the wave amplification, the needle
tip is made to act as a dipole-like sound source oscillating at a large displacement amplitude (Figure 1E), exhibiting considerably
greater time-averaged acoustic intensity at the needle tip (Figure 1A(4)) than elsewhere near the needle lumen, which carries the
energy. These characteristics have specific relevance to non-linear ultrasonics (NLU) associated with time-averaged intensity
(e.g. acoustic radiation pressure) or characterized by threshold behavior (e.g. cavitation), since the NLU phenomena can be
limited to the proximity of the needle tip.
As the ultrasound field near the needle is largely confined within a distance of few mm near the needle bevel (Figure 1A(4)),
the localization of the SonoLancet is spatially precise and microtrauma in tissues farther away from the needle tip is expected
to be minimized. Cells and tissue components influenced by the SonoLancet can be withdrawn through the needle lumen
directly from the site of ultrasound action or alternatively, cells and agents can be delivered to a spatially well-defined site in
conjunction with ultrasonic actions.
Cavitation
Large displacements in the direction of x-axis (Figure 1E) detected near the lancet point produce pronounced acoustic intensity
radiating outwards from the center axis of the needle. The high magnitude of the peak-negative-pressure, associated with the
acoustic intensity, elevates the probability of ultrasound-microbubble interactions, i.e. cavitation (Figure 1C,D). We were able
to exhibit cavitation within a region extending less than 2 mm from the tip along the positive z-direction. Optical high-speed
(HS) imaging (300000 fps) revealed that the temporal probability of observing cavitation across a time window of 100 ms can
be up to 50% in this region (Figure 1D), while in the proximity of the rest of the needle there were no signs of cavitation (Figure
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1B). This spatio-temporal (Figure 1B-D,F,G) behaviour arises from the inertial cavitation being a threshold phenomenon44.
Cavitation, i.e. growth, oscillation and collapse of gas bubbles, is a consequence of the fluctuating pressure amplitude being
momentarily the lowest in this area due to the pronounced amplification of needle tip motion compared to other locations along
the needle lumen (Figure 1B,D).
While the needle tip displacement was observed to be < 100 µm, the bubble-water boundary displacement was more
pronounced, extending beyond 300 µm along the positive x-direction. This is due to the different compliances of water and an
air bubble. The activity of the primary bubble within the SonoLancet produced fluid movements of several ms−1 (Figure 1H),
accelerations up to five orders of magnitude of gravity (Figure 1I), thus allowing production of high shear stresses localized near
the needle tip45. Collapsing bubbles produce secondary sound formation, a potential mechanism of shock wave formation46
and strong and transient shear forces have great potential to actuate matter, such as micro- and nanoparticles or tissue such as
cells, groups of cells or localized regions of an organ.
Acoustic radiation pressure
Acoustic radiation force can be employed to push or pull medium, objects and interfaces47. It is a force exerted on a target
arising from acoustic radiation pressure, which is due to a change in momentum of the acoustic wave, when the wave interacts
with such target. We here studied the capability of SonoLancet to generate acoustic radiation pressure in a suspension of
microparticles. Two main jets (Figure 2A) of microparticles (models for micro-vehicles), were emanating from opposite
sides of the needle bevel with a maximum velocity of approximately 1 mms−1 at 0.6 mm from the needle tip, decreasing
0.5 mms−1 at a distance of 2 mm mm away from the maximum. Considering the wavelength, the small object size and similar
acoustic impedance of particles compared to that of water, the main mechanism of translation arises from acoustic streaming,
i.e. acoustic radiation force exerted on the liquid, rather than acoustic radiation force directly pushing the particles. This is
supported by a finding that SonoLancet in water (22 ◦C) without microparticles induced acoustic streaming; such observation
was confirmed under Schlieren imaging (Figure 2B), which revealed a disturbance of water laminar flow (15 ◦C) close to the
sonicating needle. The results demonstrate that SonoLancet is capable of inducing acoustic radiation pressure leading to mass
transfer near the needle tip, which could be relevant to delivery of directional transportation of liquids or particles in localized
therapeutic applications such as gene and drug delivery.
Atomization
Capillary waves propagating at the water-air interface can induce micro-droplet formation at large displacement amplitudes48.
To investigate the potential of SonoLancet to produce micro-droplets, we first introduced a water droplet near the needle tip,
while the needle was embedded in air. Capillary waves were observed at low driving power levels (electrical output power «
1 W) of the transducer. At increased powers (electrical output power ∼ 1 W) crests of the waves started to extrude, eventually
forming droplets ejected from the water-air interface48. By adjusting the driving frequency, we modified the size distribution of
the deionized water droplets ejected from the surface (Figure 2C-D) from a median size of 39.5 µm down to 17.5 µm. The trend
in median droplet size is in line with the theoretical prediction:
dp = 0.34
(8piσ
ρ f 2
)1/3
(1)
where dp is the droplet size, σ is the surface tension, ρ is the density and f is the excitation frequency49. These results
demonstrate the capability of SonoLancet to produce water micro-droplets with a controlled size distribution, relevant to e.g.
delivery of therapeutic agents such as drugs or antiseptics in pulmonary conditions.
Influence of SonoLancet on a tissue phantom and tissue
As demonstrated above, the SonoLancet can induce nonlinear effects in well-defined media such as water and air. In the
following, we demonstrate SonoLancet’s influence on a tissue phantom and on excised tissue. We subjected a hydrogel tissue
phantom (10% w/v porcine gelatin, 22 ◦C) to the SonoLancet in conjunction with fluorescent nanoparticles (diameter 63 nm)
introduced to the proximity of the needle tip through the lumen. When a continuous wave of 31.7 kHz and total acoustic power
(TAP) ∼ 0.8 W were applied to the needle, the generation of cavitation bubbles and acoustic streaming was optically confirmed.
The boundary of the influenced volume extended outward from the needle tip over time (Figure 3A). After sonication was
applied together with fluorescent nanoparticles, a 3D reconstruction of the nanoparticle distributions characterized by optical
projection tomography revealed a volume containing nanoparticles is localized near the needle tip (Figure 3B). Dissection of the
phantom was used to verify that the gel was liquefied. At the highest TAP levels, ∼ 0.8 W, we recorded a temperature rise of <
2 ◦C or < 4 ◦C during a 5 or 20 s sonication, respectively, suggesting that cavitation was the main mechanism of liquefaction50,
rather than ultrasound-induced temperature rise.
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To demonstrate the influence of SonoLancet on tissue, we performed fine-needle aspiration biopsy (FNAB) with and
without ultrasound at the needle tip (ultrasound-enhanced fine-needle aspiration biopsy, USeFNAB) in different bovine tissues:
liver, kidney, spleen and striated muscle. USeFNAB contributed to increased sample yield, whose weight increased with
increasing TAP (p < 0.01), being on average up to 4x the yield obtained with FNAB in liver, 5x in kidney, 3x in spleen and
6x in muscle (Figure 3C), as compared to FNAB. When ultrasound-enhanced biopsies were performed at the highest TAP
(0.8 W), the average sample weight obtained in liver was 88.6±9.3 mg (average ± standard error deviation; n = 6) (Figure
3C(1)), 53.7±8.6 mg (n = 6) in kidney (Figure 3C(2)), 62.2±5.4 mg (n = 6) in spleen (Figure 3C(3)) and 11.9±1.9 mg (n =
6) in muscle (Figure 3C(4)); the sample masses obtained with FNAB were respectively 22.7±1.8 mg (n = 6), 11.7±2.0 mg (n
= 6), 16.6±1.0 mg (n = 6) and 1.8±0.6 mg (n = 6). Based on a histopathological evaluation, performed by a pathologist (KP)
with > 40 years of histopathology and cytopathology experience, all tissue types included intact cells and tissue (Figure 4)
containing histologically relevant structures that could be observed in all samples. The results show a systematic increase in the
sample mass with increasing TAP, as a manifestation of the actuation of tissue induced by SonoLancet.
Discussion
We successfully coupled flexural standing waves to a conventional medical needle. The converging structure of the needle bevel
seemed acoustically quite optimal at the employed frequency, because it geometrically amplified the wave allowing to generate
a highly localized and large displacements of the needle tip. The acoustic intensity of the longitudinal waves emitted from the
needle extended beyond the linear regime to nonlinear regime, suggested by large displacements < 100 µm and the observed
nonlinear effects. The maximum time-averaged acoustic intensity next to the needle bevel was more than twice compared to
that along the lumen. Since the acoustic radiation pressure associated phenomena, such as acoustic radiation force or acoustic
streaming, are proportional to intensity, the mass transfer mechanisms are pronounced at the needle tip. The long needle shaft
has multitude of resonant eigen-frequencies, which allowed changing the operation frequency. This permitted controlling the
size of the atomized droplets contrary to common ultrasound atomizers, which typically operate on a single frequency51–53.
Cavitation being a threshold phenomenon allowed generation of cavitation at will. Importantly, this was spatially restricted
to the proximity of the needle tip without observations of cavitation along the needle lumen, suggesting that these mechanisms
can be made to localize to the proximity of the needle tip. The high accelerations > 20000x the gravitational acceleration of the
bubble-water boundary suggests that extreme shear forces can be induced by this boundary to the surroundings, when cavitation
is intended. In addition, the direct effect of the rapidly moving needle tip with sharp edges provide points to exert high stress
fields on matter, such as tissue.
Minimally invasive high-frequency mechanical actuation at a known position inside the body has specific relevance to
various precision medical applications. We exemplified the influence of the SonoLancet on tissue in the FNAB application.
The forces exerted on tissue by the moving needle and cavitation bubble boundary are expected to contribute to loosen cells
and tissue constructs from the target tissue, which are then drawn into the needle by the low pressure applied with the syringe.
Depending on the tissue type, the tissue yield was increased 3-6x on average and with increasing TAP. We foresee this to
have importance especially to precision oncology, which increasingly relies on molecular assessments for therapy decisions.
However, the failure rate of molecular assessment is up to 50%9 arising mainly from inadequacy of the nucleic acids required
for determining the cancer type. This could be resolved, by obtaining a greater sample volume using SonoLancet permitting
access to greater nucleic acid quantity. The SonoLancet could contribute also to histopathological assessments, which suffer
from failure rates up to 34% due to inadequacy of tissue yield54, 55.
SonoLancet could be beneficial for precision medicine applications beyond cancer diagnostics. Controlled cavitation, used
in a variety of existing and emerging ultrasonic medical technologies56, could be exploited in personalized therapeutic and
diagnostic applications, by applying cavitation locally at the needle tip precisely at the target site. Such applications include
tumor ablation57, permeation of tissue matrix for enhanced stem cell delivery or migration, bubble-enhanced poration of
cells, i.e. sonoporation58, transfection of genetic material59 or even modifying gene expression by stimulating ultrasound18.
Moreover, cavitation-induced shock waves and associated shear forces, arising from imploding cavitation bubbles60, could be
employed for lithotripsy42 or controlled softening of calcified vessels61 with spatially precise and localized mechanical stress
gradients62. The SonoLancet could potentially serve as a way to induce streaming of biological fluids and translation of entities
inside the body. Unidirectional motion of drugs or drug nanocarriers, induced by the transfer of momentum from the wave to
the liquid, could enhance pharmaceutical effectiveness63 and facilitate applications such as targeted and localized drug, stem
cell or gene delivery. Atomization provides the ability to transform liquid into micro-droplets with control over droplet size
distribution and direction of the droplet jets allowing new platforms for delivery of drugs or cells e.g. within bodily cavities
such as those in the respiratory system.
Considering the safety, the diameter of the volume of tissue influenced by SonoLancet is comparable to that of a 11G needle
(outer diameter = 3.05 mm), while the energy is delivered through a small tract generated by a 21G needle (outer diameter
= 0.82 mm). This allows influencing a large volume of tissue in respect to the small size of the needle, while minimizing
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trauma, when accessing target site. Therefore, the SonoLancet could contribute to modifying the tissue permeability for drug
delivery applications at precise tissue locations and with extreme ultrasound exposure, or allow minimally invasive surgical
interventions via spatially precise histotripsy. Importantly, in all of these experimentations the employed ultrasound frequencies
were relatively low, < 100 kHz. Since at these frequencies the attenuation coefficients in tissue and water are small, the heat
deposition to tissue is minimized. This is supported by low temperature rise recordings < 2 ◦C and in extreme conditions < 4 ◦C.
Therefore, these findings suggest that the SonoLancet provides a minimally invasive way to influence matter via non-linear
ultrasonic mechanisms within a confined volume at the proximity of the needle without major thermal impact.
To conclude, we have functionalized the medical needle tip by nonlinear ultrasonics and, at a micrometer to millimeter
scale, and quantitatively characterized its physical properties such as cavitation, acoustic radiation pressure and atomization
within a confined volume defined as the SonoLancet. In this approach, the conventional hypodermic needle structure employs
the lumen as a conduit to bring sound energy to the needle tip. The 3D shape of the conventional needle bevel amplifies the
ultrasound action resulting in localized nonlinear effects at the proximity of the needle tip. Limiting the ultrasound action to
the SonoLancet provides spatiotemporal control of sound-tissue interaction and with respect to minimizing microtrauma of
adjacent tissues. By bringing precisely controlled ultrasound energy to a specific location in the body, the SonoLancet has the
potential to give conventional medical needles a new role in many applications relevant to precision medicine, such as tissue
biopsy, molecular diagnostics, drug or gene delivery, cell modulation, or minimally invasive surgical procedures.
Methods
Experimental arrangement
A Langevin ultrasound transducer (Figure 1A(1) and Figure 5A) was coupled via a custom-designed 3D printed aluminum
waveguide (3D Step Oy, Ylöjärvi, Finland) to a 21G × 80 mm hypodermic needle (model: 4665465, 100 STERICAN, B Braun,
Melsungen, Germany) connected to a 10 mL syringe (catalogue number: 12931031, Plastic PP Syringes Luer Slip, Fisherbrand,
Fisher Scientific, Hampton, NH, United States) (Figure 1A(1)). The device was powered by a computer-controlled combination
of an RF amplifier (model: AG 1012LF, Amplifier/Generator, T&C Power Conversion, Inc., Rochester, NY, United States) and
a function generator (model: Analog Discovery 2, Digilent, Inc., Henley Court Pullman, WA, United States), which provided
the driving signal. High speed (HS) imaging of needle actuation was employed to observe and quantify the NLU phenomena in
different experiments. The HS camera (model: Phantom V1612, Vision Research, Wayne, NJ, United States) was operated in
conjunction with a macro lens (model: Canon MP-E 65 mm f / 2.8 1-5x Macro Photo, Canon Inc., O¯ta, Tokyo, Japan) and a
general purpose lens (model: Canon EF-S 15-85 mm f / 3.5-5.6 IS USM, Canon Inc.). A white light-emitting diode (catalogue
number: 4052899910881, White Led, 3000 K, 4150 lm, Osram Opto Semiconductors, Germany) was used as a light source to
produce background light for shadowgraphy of the object during the HS camera recordings. The spatial position of the needle
tip was controlled by a motorized three-axis translation stage (model: 8MT50-100BS1-XYZ, Motorized Translation Stage,
Standa, Vilnius, Lithuania) operated by a computer user interface programmed in LabVIEW. Additionally, a combination of
a dual-axis goniometer (model: GNL20/M - Large Dual-Axis Goniometer, Thorlabs, Inc., Newton, NJ, United States) and
a continuous rotation stage (model: CR1/M - Continuous Rotation Stage, Thorlabs, Inc., Newton, NJ, United States) was
mounted on the translation stage to manually control the polar and azimuthal angle of the needle shaft.
Numerical simulation
In this study, the software COMSOL Multiphysics was used to simulate the acoustic emission of the needle in a volume of
water. The 3D geometry consists of an ultrasound transducer coupled to a 21G hypodermic needle via an S-shaped aluminum
waveguide (Figure 1A(1)). The needle shaft is surrounded by a cylindrical volume of water (external dimensions = R × H =
5 mm × 50 mm). The ultrasonic actuation of the needle is obtained by applying a potential difference of 100 V at a frequency
of 31.32 kHz across the piezoelectric stack. The pressure field in water, generated by the vibrating needle, was calculated by
performing a frequency domain analysis. The x-component of the time-average acoustic intensity, defined as Ita,x = 12 Re{pv∗x}
with p being the complex pressure and v∗x the complex conjugate of the acoustic velocity along the x-direction, was then
evaluated on the xy-plane coincident with the needle center axis (Figure 1A(4)).
Cavitation
Cavitation experiments were performed in an acrylic chamber (external dimensions = L × W × H = 21 mm × 14 mm ×
15 mm, wall thickness = 5 mm) filled with deionized water degassed to 5.8 mgL−1 (catalogue number: 11754266, Traceable
Portable Dissolved Oxygen Meter, Fisherbrand, Fisher Scientific, Hampton, NH, United States) (Figure 5B). The needle was
immersed to a depth of 45 mm from the water surface and subsequently actuated by a continuous sinusoidal signal in the
frequency range from 31 kHz to 32 kHz and emitted TAP of ∼ 0.2 W. HS recordings were taken in order to visually capture the
cavitation activity around the needle at different positions along the needle length. More specifically 45 videos (sample rate =
300000 frames per second (fps), exposure = 2.8 µs, resolution = 128 pixels×112 pixels, lens aperture = 3.3; lens model: Canon
5/16
MP-E 65 mm) were acquired, covering a total length of 45 mm from the needle tip to the waveguide. The HS videos were
finally analyzed by an algorithm implemented in MATLAB capable of tracking the needle position over time and quantify
the cavitation activity. The needle displacement along the x-axis from its rest position was measured using sub-pixel image
registration by cross-correlation in the frequency domain64 between the ith frame Ii(x,y) and the first frame I1(x,y) of the high
speed footage as follows:
∆xi = argmax
x
(FFT{Ii(x,y)} ·FFT{I1(x,y)}∗) (2)
where ∆xi is the measured needle x-displacement from the rest position and FFT is the two-dimensional fast Fourier transform.
In order to quantify the projected area of cavitation a new set of frames, where only the cavitation activity is present, is created.
This is done by subtracting the reference image I1 (rigidally translated by ∆xi in order to match the needle position in the ith
frame) from each frame of the original footage:
Icavitation,i(x,y) = iFFT{(FFT{Ii(x,y)}− (FFT{I1(x+∆xi,y)}} (3)
where iFFT is the two-dimensional discrete inverse Fourier transform. A probability map Pcavitation(x,y), in which the value of
each pixel represents the probability to observe a cavitation event in a specific coordinate, is then measured as follows:
Pcavitation(x,y) =
100
N
N
∑
i=1
Icavitation,bw,i(x,y), (4)
where N is the total number of frames and Icavitation,bw(x,y) is a frame-set generated by thresholding Icavitation(x,y) with the
Otsu method65. The projected area of cavitation as a function of time is then obtained:
Acavitation,i =
∫ ∫
Icavitation,bw,i(x,y)dx dy (5)
Finally, a total of 45 probability maps were vertically concatenated to reproduce the entire length from the needle tip to the
waveguide.
Atomization
The purpose of this experiment was to demonstrate that with an ultrasonically actuated needle one can eject micro-droplets
from the needle tip surface and control the droplet size distribution. A droplet of deionized water was introduced near the
needle tip, while the needle was embedded in air (Figure 5C). HS recordings of the atomization process were acquired with the
following settings: sample rate = 16653 fps, exposure = 10 µs, resolution = 768 pixels × 768 pixels, lens aperture = 16 (lens
model: Canon MP-E 65 mm). The video frames were then analyzed in MATLAB to determine the droplet size distribution for
different excitation frequencies and to compare it with theoretical predictions. Each frame Ii(x,y) was first segmented with an
adaptive thresholding66. Then, the built-in MATLAB function ‘regionprops’ was applied to measure the area and the equivalent
diameter for each 8-connected component in the binary image Ibw,i(x,y). Finally, the median droplet diameter distribution was
calculated over N = 1000 randomly selected frames and compared with theoretical predictions defined by Equation (1).
Acoustic streaming
Polystyrene based microparticles with a diameter of 30 µm (catalogue number: 84135-5ML-F, Micro particles based on
polystyrene analytical standard, size: 30 µm, Sigma-Aldrich, St. Louis, MO, United States) were used to visualize their
translations near the needle tip. The test was conducted in a plastic cuvette (external dimensions = L ×W × H = 12 mm ×
12 mm × 45 mm, wall thickness = 1 mm) filled with deionized water (3 mL) with a particle concentration of 0.05% v/v (Figure
5D). A low power continuous sinusoidal signal (TAP = 0.1 W) was applied to the needle, whose action was recorded with
the following care settings: sample rate = 10000 fps, exposure = 2 µs, resolution = 1024 pixels × 800 pixels, lens aperture =
2.8 (lens model: Canon MP-E 65 mm). An averaged velocity field V¯ (x,y) = v¯xxˆ+ v¯yyˆ, being xˆ and yˆ unit vectors, was then
calculated by employing a cross-correlation technique67. Each frame Ii(x,y) is divided into small interrogation boxes of the
size of 64 pixels × 64 pixels. Considering Ii(x,y) and Ii+1(x,y)to be the frames recorded at time t and t+dt , let f (x,y) be an
interrogation box centered at specific location (x,y) in Ii(x,y) and g(x,y) an interrogation box centered at specific location (x,y)
in Ii+1(x,y). The displacement field~u(x,y) of two consecutive frames is calculated by measuring the offset (∆x,∆y) of the peak
of the correlation map between f (x,y) and g(x,y) as follows:
∆xi = argmax
x
(FFT{g(x,y)} ·FFT{ f (x,y)}∗),
∆yi = argmax
y
(FFT{g(x,y)} ·FFT{ f (x,y)}∗),
~ui(x,y) = ∆xi(x,y)xˆ+∆yi(x,y)yˆ.
(6)
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The averaged velocity map is then calculated as:
V¯ (x,y) =
1
N
N
∑
i=1
∂
∂ t
~ui(x,y), (7)
where N = 1000 is the total number of frames.
Schlieren imaging
The experiment was performed in a glass chamber (external dimensions = L × W × H = 250 mm × 250 mm × 250 mm,
wall thickness = 4 mm) filled with deionized and degassed water of temperature T = 22 ◦C as measured by a thermocouple
thermometer (model: FLUKE T3000 FC, Fluke, Everett, WA, United States). A laminar flow of water (15 ◦C, v = 0.3 ms−1)
emanating from a secondary 21G needle directed towards SonoLancet (Figure 2B and 5E) was generated on a plane parallel to
the needle center axis. Ultrasound continuous waves of 31.7 kHz and a TAP ∼ 0.8 W were applied to the needle for 10 s. HS
Schlieren recordings of the disturbance of a water laminar flow induced by the needle action were acquired (sample rate =
100000 fps, exposure = 0.357 µs, resolution = 128 pixels × 128 pixels, lens model: Canon EF-S 15-85 mm).
Tissue phantom experiment
Experiments in a tissue phantom (10% w/v porcine gelatin/deionized water, catalogue number: 53028, Gelatin from bovine and
porcine bones for ballistic analysis Type 1, Honeywell Fluka, Morris Plains, NJ, United States) were carried out in combination
with the ultrasonically actuated needle pre-filled with contrast agent (0.1% w/v, fluorescent particles/deionized water, catalogue
number: 11894932, Fluoro-Max Dyed Red Aqueous Fluorescent Particles, Thermo Fisher Scientific, Waltham, MA, United
States). The needle was inserted to a depth of 7 mm from the gelatin surface, penetrating three times the sample in order to let
the contrast agent wet the walls of the created cavity. Continuous ultrasound wave at 31.4 kHz and TAP ∼ 0.8 W was applied
to the needle for 10 s. HS videos of projections of the volume of interaction between the gelatin and the SonoLancet were taken
using the following settings: sample rate = 1000 fps, exposure = 10 µs, resolution = 768 pixels × 768 pixels, lens aperture =
16 (lens model: Canon MP-E 65 mm). Optical projection tomography scanning of the sample was performed using an OPT
scanner (Bioptonics OPT 3001M Scanner). Reconstructed images (resolution = 512 pixels × 512 pixels), which represent the
intersection between planes perpendicular to the needle center-axis and the volume of actuation in the tissue phantom, were
generated using NRecon version 1.6.1.0 (Skyscan) software and further analyzed in MATLAB. Each reconstructed image Iz(x,y)
was first thresholded with the Otsu method. A sequence of morphological erosion and dilation using a disk-shaped structuring
element of radius r = 10pixels was then applied to fill eventual gaps in the image and remove small unwanted objects arising
from noise. Contours of the sections, defined as sequences of n contour points {P0,P1, . . . ,Pn−1}, are extrapolated from the
images and filtered with a Savitzky-Golay finite impulse response (FIR) smoothing filter (polynomial order = 2, window size =
11). Finally, the 3D surface of actuation around the needle tip is constructed with triangular elements and further adjusted in
Fusion 360.
USeFNAB
We quantified the ultrasound-tissue interaction by measuring the tissue yield of ultrasound-enhanced fine-needle aspiration
biopsies obtained from bovine liver, kidney, spleen and muscle at 4 different TAP levels (0 W control; sonication groups: 0.2 W,
0.5 W, 0.8 W) with the yield obtained with the conventional fine-needle aspiration biopsy approach (FNAB control) having the
same syringe (10 mL) and needle (21G × 80 mm) as USeFNAB. Liver (from 33 months old female bovine), kidney (from 33
months old male bovine), spleen (from 55 months old female bovine) and striated muscle (diaphragm, from 19 months old
female bovine) specimens were obtained from the slaughterhouse (Vainion Teurastamo Oy, Orimattila, Finland) within 1 h post
mortem and experiments were performed 3-5 h post mortem at room temperature (22-24 ◦C). Only peripheral parts of the same
liver were used, to avoid large blood vessels and acquisition of bloody samples. In liver and in spleen, samples were taken at a
depth of 2 cm from the organ surface by keeping the needle parallel to the table, where the target tissue is fixed throughout
the procedure. Sample acquisition in kidney was limited to the cortical area and each biopsy was performed in different renal
lobes, while, in muscle, biopsies were taken along the fibre orientation. The used needles and syringes were weighed before
and after the biopsies using a balance with resolution of 0.1 mg (model: Quintix Precision Balance 5,100 g ×10 mg, Sartorius
AG, Germany) to measure the mass of the sample extracted from the tissue. The test was divided into 6 sets of 5 repetition. In
each set, the order of the groups to be tested (FNAB (n = 6); USeFNAB: 0 W (n = 6), 0.2 W (n = 6), 0.5 W (n = 6) and 0.8 W
(n = 6)) was randomized with a random permutation within a set of five samples (one sample from each group). The FNAB
procedure consisted of inserting the tip of the needle into the target tissue using a ‘fanning technique’, pulling the plunger back
to the 2 mL mark and moving the needle back and forth 7 times with a frequency of 1 pass per second. The penetration depth
was approximately 15 mm at a targeted angular offset of approximately 5◦ between the passes. The suction was maintained
throughout the biopsy sampling and only released after the needle was withdrawn68. The same procedure was adopted for
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USeFNABs, where the ultrasound was applied throughout the biopsy after the needle was inserted into the tissue. Assuming
that normal distribution does not apply, the FNAB mass was compared to the masses of USeFNAB groups using the two-sided
non-parametric Wilcoxon test. The Bonferroni-corrected level of statistical significance was 0.0125.
Histology
Biopsy samples were processed into agarose cell blocks for histological assessment69. Aspirates were expressed into 1.5 mL
tubes (11569914, Snap Cap Low Retention Microcentrifuge Tubes, Thermo Fisher Scientific, Waltham, MA, United States)
containing 500 µL of 1x PBS (BP399-4, Phosphate Buffered Saline, 10X Solution, Fisher BioReagents, Fisher Scientific,
Hampton, NH, United States) and subjected to centrifugation at 500 G for 5 min. After a second PBS washing, pellets
were resuspended in 500 µL of 10% neutral buffered formalin (15817114, HistoTainer, Simport, Saint-Mathieu-de-Beloeil,
Quebec, Canada). After 10 min of incubation time, tubes were centrifuged at 500 G for 5 min, then, the supernatant was
carefully discarded, and pellets were washed in PBS twice. Excess PBS was carefully removed and formalin fixed pellets were
resuspended in 100 µL of molten agarose (10377033, Agarose Low-Melting, Nucleic Acid Recovery/Molecular Biology Grade,
Thermo Fisher Scientific, Waltham, MA, United States) kept at 42 ◦C and gently centrifuged at 180 G for 1 min. The agarose
cell blocks were let solidify at 4 ◦C and then transferred into 70% v/v ethanol (172381, 70% v/v Ethanol Solution Molecular
Biology Grade, Fisher Scientific, Hampton, NH, United States) pre-filled tubes. Several sections of the paraffin embedded
cell blocks (4 to 5 for each sample) were cut at 5 µm thickness, mounted on 25 mm × 75 mm slides (J1800AMNZ, SuperFrost
Plus Adhesion slides, Thermo Fisher Scientific, Waltham, MA, United States) and stained with hematoxylin and eosin (H&E).
Finally, microscopy pictures (bright field, 20x magnification, extended focus) were generated using 3DHISTECH Panoramic
250 FLASH II digital slide scanner. Four biopsy samples (liver, n = 1; spleen, n = 1; muscle, n = 2) failed to be processed for
histological analysis due to breakage of the agarose cell block.
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Figure 1. (A(1)) Schematic represents the investigational device that comprises a conventional Langevin ultrasound
transducer coupled via an aluminum waveguide to a (A(2-3)) 21G hypodermic needle connected to a 10 mL syringe. The
geometry permits connecting virtually any pressure source to the needle. (A(4)) Numerical simulation result representing the
x-component of the time-average acoustic intensity within the xy-plane coincident with the needle center axis demonstrates
localization of sound energy at the very tip of the needle, more than double the intensity compared that near the needle lumen.
(B,D) The projected spatial probability of cavitation in deionized water ([O2] 5.8 mgL−1) reveals that cavitation is highly
concentrated at the needle tip, as exemplified in (C). (F,G) Temporally we observed a cavitation onset after which the inertial
cavitation events continued in an uninterrupted manner. (H) The applied ultrasound induced peak velocities up to 5 ms−1 and
(I) acceleration of the bubble and water boundary that was equivalent to 20000 G. The results demonstrate that a conventional
medical needle can be converted into a highly controlled, ultrasonically functionalized instrument with significant NLU
phenomena concentrated at the very tip of the needle.
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Figure 2. (A) 30 µm diameter polystyrene microparticles were used to visualize the water flow pattern around the needle
during sonication. The graph represents the time-averaged velocity field of the particles, calculated across a time window of
100 ms. (B) Schlieren images show the disturbance of water laminar flow induced by the needle action as a demonstration of
acoustic streaming taking place around the needle tip during sonication. (C) The droplet size distribution was controlled with
ultrasonic driving frequencies and followed the theoretical relationship. This is exemplified in HS imaging (D), which revealed
micro-droplet ejections of water at different driving frequencies from a main water drop hanging from the needle when the
needle was embedded in air. (A, B) The results demonstrate the capability of SonoLancet to induce mass transfer as well as (C,
D) controlling the size of atomized droplets. On each box, the central mark represents the median, and the lower and upper
edges of the box indicate the 25th and 75th percentiles, respectively. The whiskers extend to the most extreme values of the
data set excluding the outliers, and the outliers are plotted individually with non-filled circles.
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Figure 3. (A) HS imaging of experiments in tissue phantom (10% w/v ballistic gelatin/deionized water) reveals projections of
the volume of interaction between the gelatin and the Sonance at different time points during continuous sonication. (B) A 3D
reconstruction of the actuated region was produced by examining the sample under optical projection tomography. (C) The
mass of extracted sample in ultrasound enhanced biopsies performed in bovine (C(1)) liver, (C(2)) kidney, (C(3)) spleen and
(C(4)) muscle at different power levels compared to the standard FNAB. The needle employed in FNAB and
ultrasound-enhanced FNAB (USeFNAB) was the same 21G needle. In the bar charts, the bar height represents the mean of the
data set and the error bar indicates the standard deviation. Individual data points are shown as white-filled circles.
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Figure 4. Histological pictures (20x) of cell block sections prepared from biopsy aspirates taken from different bovine organs
(top to bottom: liver, kidney, spleen and muscle) at different TAP levels (left to right: FNAB, USeFNAB 0 W, 0.2 W, 0.5 W and
0.8 W). The results demonstrated that different tissue types included histopathologically relevant cells or tissue constructs,
suggesting that SonoLancet could allow histopathological evaluation of samples in selected FNAB applications, if developed to
its full potential.
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Figure 5. Experimental arrangements: (A) Simplified schematics of the ultrasound system arrangement with optical detection
of needle tip activity, (B) cavitation experiment, (C) atomization experiment, (D) acoustic streaming experiment and the (E)
Schlieren imaging experiment.
16/16
